Zhu, S., Quan, C., Wei, H. (2025). Neoadjuvant lenvatinib plus pembrolizumab for resectable clear-cell renal cell carcinoma (PELUR): A prospective phase 2 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4541